Krsnaa Diagnostics Ltd. (KRSNAA) Diagnostics 52 Week Low Streak Extends for Second Straight Session

Krsnaa Diagnostics Ltd. (KRSNAA) has now traded within 2% of its 52-week low for its second straight session, with the stock down 1.22% across the streak so far. At 9:23 AM IST, it traded at Rs 506, after touching an intraday low of Rs 506. The latest Univest data confirms the repeated low-price pattern, but it does not establish a company-specific cause for the continued weakness.

The stock had previously traded at Rs 514.95, opened the day at Rs 525.2 and touched a high of Rs 525.2 before moving lower into its current range. With a market capitalisation of Rs 1,661.67 crore, the repeated near-low pattern matters more than a single session because it shows sustained pressure around the same price zone rather than one isolated move. For readers tracking Krsnaa Diagnostics share price, the focus is on whether the pattern persists or begins to stabilise.

Krsnaa Diagnostics Ltd. (KRSNAA) 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 506
Previous Close	Rs 514.95
Today's Move	Rs -8.95 (-1.74%)
Open	Rs 525.2
High	Rs 525.2
Low	Rs 506
Market Capitalisation	Rs 1,661.67 crore

Krsnaa Diagnostics Ltd. (KRSNAA) traded at Rs 506 versus the previous close of Rs 514.95, a fall of 1.74%. The stock opened at Rs 525.2, reached a high of Rs 525.2, touched a low of Rs 506.

Krsnaa Diagnostics share price was trading at Rs 506 at 9:23 AM IST, down Rs 8.95 or 1.74% from the previous close of Rs 514.95. The stock opened at Rs 525.2 and also marked the day’s high at Rs 525.2, which means it began the market near the upper end of its range before steadily weakening and revisiting the day’s low at Rs 506. The current price is sitting at the lower edge of the intraday band, which keeps the decline in focus for anyone following Krsnaa Diagnostics stock news.

The market capitalisation stood at Rs 1,661.67 crore, placing the company in a mid-range valuation bracket by size, though size alone says nothing about operating quality. The broader read from Krsnaa Diagnostics share price today is that the stock is not merely moving lower once; it is repeatedly testing the same weak price area. That is why the Krsnaa Diagnostics 52 Week Low Streak matters as a pattern, not just as a one-day move. It also means the current Krsnaa Diagnostics share price update deserves attention alongside fundamentals and sector comparison rather than as a standalone intraday change.

Why Krsnaa Diagnostics Ltd. (KRSNAA) May Be Moving Today

According to recent news reports, Krsnaa Diagnostics has announced a strategic collaboration with Azmed, a global innovator in radiology AI, in a move that may be linked to the day’s price action only as a possibility. The partnership is intended to build a platform that could improve reporting efficiency and support scalable growth, which makes the update relevant to the company’s operating outlook. At the same time, the stock remains in a decline story, so the news should be read neutrally rather than as evidence of a reversal. It also does not override the broader Krsnaa Diagnostics 52 Week Low Streak pattern.

What the Repeated 52-Week Lows Show

The Krsnaa Diagnostics 52 Week Low Streak is now in its second straight session, and that repetition is the main signal from the latest price pattern. Across the streak, the stock has declined 1.22%, which is a small but useful cumulative measure because it shows the weakness has persisted rather than appearing as a one-off dip. In a near 52-week low streak, the more important question is not whether the stock bounced within the day, but whether it can move away from the one-year trough zone and stay there.

For Krsnaa Diagnostics share price today, the repeated low-area trading suggests the market is still reassessing the stock’s near-term setup. The latest Univest data confirms the price pattern, but it does not establish a company-specific cause for the continued move. That distinction matters: readers should separate the observed price action from any unsupported story about why it is happening. In other words, the Krsnaa Diagnostics 52 Week Low Streak tells us the stock remains under pressure, but it does not by itself explain the reason.

Krsnaa Diagnostics Ltd. (KRSNAA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,661.67 crore
P/E Ratio	17.14x
P/B Ratio	1.69x
ROE	10.97%
ROCE	13.08%
EPS	Rs 30.04
Book Value Per Share	Rs 304.78
Dividend Yield	0.39%

Krsnaa Diagnostics Ltd. (KRSNAA) fundamental metrics show P/E 17.14x, P/B 1.69x, ROE 10.97%, ROCE 13.08%. These figures provide context only and are not a buy or sell signal.

Krsnaa Diagnostics Ltd. has a market capitalisation of Rs 1,661.67 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.14x, P/B at 1.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.97% and ROCE of 13.08%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 30.04, book value per share of Rs 304.78, dividend yield of 0.39%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 33.13x, median ROE of 13.07%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	17.14x
Benchmark Median P/E	33.13x
Benchmark Average P/E	80.9x
Benchmark P/E Range	0x to 1,528.53x
Company P/B Ratio	1.69x
Benchmark Median P/B	3.77x
Company ROE	10.97%
Benchmark Median ROE	13.07%
Company ROCE	13.08%
Benchmark Median ROCE	15.83%
Company Market Capitalisation	Rs 1,661.67 crore
Benchmark Median Market Cap	Rs 505.79 crore

Krsnaa Diagnostics Ltd. (KRSNAA) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Krsnaa Diagnostics Ltd. (KRSNAA) has a P/E ratio of 17.14x, which is below the benchmark median of 33.13x, a difference of -48.26%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Krsnaa Diagnostics Ltd. (KRSNAA) has a ROE of 10.97%, which is below the benchmark median of 13.07%, a difference of -16.07%. Krsnaa Diagnostics Ltd. (KRSNAA) has a ROCE of 13.08%, which is below the benchmark median of 15.83%, a difference of -17.37%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
SURAKSHA DIAGNOSTIC LIMITED	SURAKSHA	1,549.92	42.1	5.87	13.81	24.97
GUJARAT KIDNEY N SUP SP L	GKSL	1,484.22	91.59	5.63	12.08	15.51
Shalby Ltd.	SHALBY	1,371.72	33.13	1.28	3.48	6.88
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,407.74	31.59	6.51	25.22	29.21
GPT Healthcare Ltd.	GPTHEALTH	1,146.72	23.64	3.96	16.32	23.06

Krsnaa Diagnostics Ltd. (KRSNAA) has a P/E ratio of 17.14x compared with the displayed peer median of 33.13x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.97% compares with a peer median of 13.81% across the companies shown in the table. ROCE stood at 13.08% versus the displayed peer median of 23.06%, providing a capital-efficiency comparison. Krsnaa Diagnostics Ltd. (KRSNAA) has a market capitalisation of Rs 1,661.67 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.

Why Investors Are Watching

• The Krsnaa Diagnostics 52 Week Low Streak has continued for a second straight session, keeping the share price near its one-year low zone.
• The cumulative decline across the streak is 1.22%, which shows a repeated weak pattern rather than a single-day slip.
• Krsnaa Diagnostics share price is moving with moderate valuation multiples, but the stock is still lagging the broader listed healthcare peer set on profitability.
• The latest news about the Azmed collaboration may be relevant to future execution, although it does not by itself explain the current decline.
• Investors may monitor whether Krsnaa Diagnostics stock can move away from the near-low band and whether fundamentals begin to support the current valuation more clearly.

About the Company

Krsnaa Diagnostics Ltd. operates in the Hospital & Healthcare Services industry under the Healthcare sector. The company’s listed profile places it among diagnostic and healthcare service names that are often assessed on a mix of execution, margins, capital efficiency and valuation discipline. With a market capitalisation of Rs 1,661.67 crore, Krsnaa Diagnostics is large enough to attract sustained market attention, yet it still trades in a range where sentiment can move the share price materially.

The Krsnaa Diagnostics share price today will therefore remain sensitive to both business updates and how the market values earnings quality. The current Krsnaa Diagnostics 52 Week Low Streak shows that recent price action has been weak, but the company’s operating profile and peer-relative valuation also matter for any longer view on the stock’s stock performance.

Frequently Asked Questions

What does the Krsnaa Diagnostics 52 Week Low Streak mean?

Ans. It means the stock has traded within 2% of its 52-week low for two straight sessions. The repeated pattern shows sustained weakness near the one-year low zone rather than an isolated intraday move.

Is a company-specific cause confirmed for the decline?

Ans. No. The latest Univest data confirms the price pattern, but it does not establish a company-specific cause for the continued weakness. Any link to news should be treated cautiously unless supported by direct evidence.

How is Krsnaa Diagnostics valued versus its sector?

Ans. Krsnaa Diagnostics trades at a P/E of 17.14 and a P/B of 1.69, both below the healthcare industry medians supplied here. That points to a more conservative valuation than many listed healthcare peers.

What do the return ratios suggest?

Ans. The company reports ROE of 10.97% and ROCE of 13.08%. These levels are useful but are still below the industry medians in the latest Univest peer set, so the profitability profile is not leading the group.

Did the Azmed partnership affect Krsnaa Diagnostics share price today?

Ans. The news may be linked to the move as a possibility, but not as proven causation. It is best read as a strategic update that may matter over time, while the stock still trades near its yearly low.

What should readers watch next in Krsnaa Diagnostics stock news?

Ans. Readers should track whether the stock remains near the same low band, how the market responds to company updates, and whether profitability and valuation begin to look more aligned. Those factors matter more than one intraday print alone.

Track Krsnaa Diagnostics Ltd. (KRSNAA) Share Price on Univest

Use Krsnaa Diagnostics Ltd. (KRSNAA) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.